Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$398,382
+$10,092 QoQ
Shares Held
2,542
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#994
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GF FUND MANAGEMENT CO. LTD. holds $158,510,415 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
129,406 | $46,860,500 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
300,113 | $37,916,276 | |
| 3 | LLY |
ELI LILLY & Co
|
22,453 | $26,930,804 | |
| 4 | JNJ |
Johnson & Johnson
|
65,712 | $16,688,876 | |
| 5 | ABBV |
AbbVie Inc.
|
48,257 | $12,143,391 | |
| 6 | MRK |
Merck & Co., Inc.
|
68,652 | $8,821,782 | |
| 7 | PFE |
Pfizer Inc
|
156,777 | $3,775,190 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,106 | $3,232,827 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,382 | 2,542 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $388,290 | 2,542 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $588,980 | 4,272 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $325,986 | 2,542 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $307,607 | 2,542 | Shares | Sole | 2025-07-22 | |
| No filing history on record for this holder in this stock. | ||||||